PEDIATRÍA
Fachbereich
Hamad Medical Corporation
Doha, QatarPublikationen in Zusammenarbeit mit Forschern von Hamad Medical Corporation (1)
2020
-
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Journal of Allergy and Clinical Immunology, Vol. 145, Núm. 5, pp. 1452-1463